In the current signature consisting of five NSRlncRNAs (AC092611.2, NNT-AS1, AGAP2-AS1, AC147651.3, and AC007406.3), several NSRlncRNAs have been claimed to be involved in the carcinogenesis including ccRCC, or have an influence on the prognosis of patients with malignant renal tumor. Here, AGAP2 is linked to nonpapillary renal cell carcinoma.